Mante M - Search Results

1

Mutant alpha-synuclein exacerbates age-related decrease of neurogenesis.

Winner B, Rockenstein E, Lie DC, Aigner R, Mante M, Bogdahn U, Couillard-Despres S, Masliah E, Winkler J. Winner B, et al. Among authors: mante m. Neurobiol Aging. 2008 Jun;29(6):913-25. doi: 10.1016/j.neurobiolaging.2006.12.016. Epub 2007 Jan 31. Neurobiol Aging. 2008. PMID: 17275140 Free PMC article.

2

GP120 and tenofovir alafenamide alter cannabinoid receptor 1 expression in hippocampus of mice.

Kulbe JR, Le AA, Mante M, Florio J, Laird AE, Swinton MK, Rissman RA, Fields JA. Kulbe JR, et al. Among authors: mante m. J Neurovirol. 2023 Oct;29(5):564-576. doi: 10.1007/s13365-023-01155-x. Epub 2023 Oct 6. J Neurovirol. 2023. PMID: 37801175 Free PMC article.

3

Correction: GP120 and tenofovir alafenamide alter cannabinoid receptor 1 expression in hippocampus of mice.

Kulbe JR, Le AA, Mante M, Florio J, Laird AE, Swinton MK, Rissman RA, Fields JA. Kulbe JR, et al. Among authors: mante m. J Neurovirol. 2024 Feb;30(1):101-102. doi: 10.1007/s13365-023-01192-6. J Neurovirol. 2024. PMID: 38177832 Free PMC article. No abstract available.

4

Differential neurotrophic effects of apolipoprotein E in aged transgenic mice.

Veinbergs I, Mallory M, Mante M, Rockenstein E, Gilbert JR, Masliah E. Veinbergs I, et al. Among authors: mante m. Neurosci Lett. 1999 Apr 23;265(3):218-22. doi: 10.1016/s0304-3940(99)00243-8. Neurosci Lett. 1999. PMID: 10327170

5

beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor.

Hashimoto M, Rockenstein E, Mante M, Mallory M, Masliah E. Hashimoto M, et al. Among authors: mante m. Neuron. 2001 Oct 25;32(2):213-23. doi: 10.1016/s0896-6273(01)00462-7. Neuron. 2001. PMID: 11683992 Free article.

6

Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42).

Rockenstein E, Mallory M, Mante M, Sisk A, Masliaha E. Rockenstein E, et al. Among authors: mante m. J Neurosci Res. 2001 Nov 15;66(4):573-82. doi: 10.1002/jnr.1247. J Neurosci Res. 2001. PMID: 11746377

7

Effects of Cerebrolysin on amyloid-beta deposition in a transgenic model of Alzheimer's disease.

Rockenstein E, Mallory M, Mante M, Alford M, Windisch M, Moessler H, Masliah E. Rockenstein E, et al. Among authors: mante m. J Neural Transm Suppl. 2002;(62):327-36. J Neural Transm Suppl. 2002. PMID: 12456076

8

The neuroprotective effects of Cerebrolysin in a transgenic model of Alzheimer's disease are associated with improved behavioral performance.

Rockenstein E, Adame A, Mante M, Moessler H, Windisch M, Masliah E. Rockenstein E, et al. Among authors: mante m. J Neural Transm (Vienna). 2003 Nov;110(11):1313-27. doi: 10.1007/s00702-003-0025-7. J Neural Transm (Vienna). 2003. PMID: 14628195

9

An antiaggregation gene therapy strategy for Lewy body disease utilizing beta-synuclein lentivirus in a transgenic model.

Hashimoto M, Rockenstein E, Mante M, Crews L, Bar-On P, Gage FH, Marr R, Masliah E. Hashimoto M, et al. Among authors: mante m. Gene Ther. 2004 Dec;11(23):1713-23. doi: 10.1038/sj.gt.3302349. Gene Ther. 2004. PMID: 15483670

10

Amelioration of the cerebrovascular amyloidosis in a transgenic model of Alzheimer's disease with the neurotrophic compound cerebrolysin.

Rockenstein E, Adame A, Mante M, Larrea G, Crews L, Windisch M, Moessler H, Masliah E. Rockenstein E, et al. Among authors: mante m. J Neural Transm (Vienna). 2005 Feb;112(2):269-82. doi: 10.1007/s00702-004-0181-4. Epub 2004 Jul 7. J Neural Transm (Vienna). 2005. PMID: 15657642

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters